View in EDS

A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.

Saved in:
Bibliographic Details
Title: A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
Authors: McDermott DH; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases., Velez D; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases., Cho E; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases., Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases., DiGiovanna JJ; Laboratory of Cancer Biology and Genetics and., Pastrana DV; Laboratory of Cellular Oncology, National Cancer Institute., Buck CB; Laboratory of Cellular Oncology, National Cancer Institute., Calvo KR; Department of Laboratory Medicine, Clinical Center., Gardner PJ; Office of the Clinical Director, National Institute of Dental and Craniofacial Research., Rosenzweig SD; Department of Laboratory Medicine, Clinical Center., Stratton P; National Institute of Neurologic Disorders and Stroke., Merideth MA; Office of the Clinical Director, National Human Genome Research Institute., Kim HJ; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and., Brewer C; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and., Katz JD; Rheumatology Fellowship and Training Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA., Kuhns DB; Leidos Biomedical Research Inc., Frederick, Maryland, USA., Malech HL; Laboratory of Clinical Immunology and Microbiology and., Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Fay MP; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Murphy PM; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
Source: The Journal of clinical investigation [J Clin Invest] 2023 Oct 02; Vol. 133 (19). Date of Electronic Publication: 2023 Oct 02.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37561579
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22McDermott+DH%22">McDermott DH</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.<br /><searchLink fieldCode="AU" term="%22Velez+D%22">Velez D</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.<br /><searchLink fieldCode="AU" term="%22Cho+E%22">Cho E</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.<br /><searchLink fieldCode="AU" term="%22Cowen+EW%22">Cowen EW</searchLink>; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases.<br /><searchLink fieldCode="AU" term="%22DiGiovanna+JJ%22">DiGiovanna JJ</searchLink>; Laboratory of Cancer Biology and Genetics and.<br /><searchLink fieldCode="AU" term="%22Pastrana+DV%22">Pastrana DV</searchLink>; Laboratory of Cellular Oncology, National Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Buck+CB%22">Buck CB</searchLink>; Laboratory of Cellular Oncology, National Cancer Institute.<br /><searchLink fieldCode="AU" term="%22Calvo+KR%22">Calvo KR</searchLink>; Department of Laboratory Medicine, Clinical Center.<br /><searchLink fieldCode="AU" term="%22Gardner+PJ%22">Gardner PJ</searchLink>; Office of the Clinical Director, National Institute of Dental and Craniofacial Research.<br /><searchLink fieldCode="AU" term="%22Rosenzweig+SD%22">Rosenzweig SD</searchLink>; Department of Laboratory Medicine, Clinical Center.<br /><searchLink fieldCode="AU" term="%22Stratton+P%22">Stratton P</searchLink>; National Institute of Neurologic Disorders and Stroke.<br /><searchLink fieldCode="AU" term="%22Merideth+MA%22">Merideth MA</searchLink>; Office of the Clinical Director, National Human Genome Research Institute.<br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink>; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and.<br /><searchLink fieldCode="AU" term="%22Brewer+C%22">Brewer C</searchLink>; Otolaryngology Branch, National Institute on Deafness and other Communication Disorders, and.<br /><searchLink fieldCode="AU" term="%22Katz+JD%22">Katz JD</searchLink>; Rheumatology Fellowship and Training Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kuhns+DB%22">Kuhns DB</searchLink>; Leidos Biomedical Research Inc., Frederick, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Malech+HL%22">Malech HL</searchLink>; Laboratory of Clinical Immunology and Microbiology and.<br /><searchLink fieldCode="AU" term="%22Follmann+D%22">Follmann D</searchLink>; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fay+MP%22">Fay MP</searchLink>; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Murphy+PM%22">Murphy PM</searchLink>; Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2023 Oct 02; Vol. 133 (19). <i>Date of Electronic Publication: </i>2023 Oct 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37561579
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/JCI164918
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McDermott DH
      – PersonEntity:
          Name:
            NameFull: Velez D
      – PersonEntity:
          Name:
            NameFull: Cho E
      – PersonEntity:
          Name:
            NameFull: Cowen EW
      – PersonEntity:
          Name:
            NameFull: DiGiovanna JJ
      – PersonEntity:
          Name:
            NameFull: Pastrana DV
      – PersonEntity:
          Name:
            NameFull: Buck CB
      – PersonEntity:
          Name:
            NameFull: Calvo KR
      – PersonEntity:
          Name:
            NameFull: Gardner PJ
      – PersonEntity:
          Name:
            NameFull: Rosenzweig SD
      – PersonEntity:
          Name:
            NameFull: Stratton P
      – PersonEntity:
          Name:
            NameFull: Merideth MA
      – PersonEntity:
          Name:
            NameFull: Kim HJ
      – PersonEntity:
          Name:
            NameFull: Brewer C
      – PersonEntity:
          Name:
            NameFull: Katz JD
      – PersonEntity:
          Name:
            NameFull: Kuhns DB
      – PersonEntity:
          Name:
            NameFull: Malech HL
      – PersonEntity:
          Name:
            NameFull: Follmann D
      – PersonEntity:
          Name:
            NameFull: Fay MP
      – PersonEntity:
          Name:
            NameFull: Murphy PM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 10
              Text: 2023 Oct 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1558-8238
          Numbering:
            – Type: volume
              Value: 133
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: The Journal of clinical investigation
              Type: main
ResultId 1